A GATA/RUNX cis-regulatory module couples Drosophila blood cell commitment and differentiation into crystal cells  by Ferjoux, Géraldine et al.
Developmental Biology 305 (2007) 726–734
www.elsevier.com/locate/ydbioGenomes & Developmental Control
A GATA/RUNX cis-regulatory module couples Drosophila blood cell
commitment and differentiation into crystal cells
Géraldine Ferjoux, Benoit Augé, Karène Boyer, Marc Haenlin ⁎, Lucas Waltzer ⁎
Centre de Biologie du Développement, UMR 5547, CNRS/Université Paul Sabatier Toulouse III, 118 route de Narbonne, 31062 Toulouse, France
Received for publication 3 January 2007; revised 12 February 2007; accepted 7 March 2007
Available online 13 March 2007Abstract
Members of the RUNX and GATA transcription factor families play critical roles during hematopoiesis from Drosophila to mammals. In
Drosophila, the formation of the crystal cell hematopoietic lineage depends on the continuous expression of the lineage-specific RUNX factor
Lozenge (Lz) and on its interaction with the GATA factor Serpent (Srp). Crystal cells are the main source of prophenoloxidases (proPOs), the
enzymes required for melanization. By analyzing the promoter regions of several insect proPOs, we identify a conserved GATA/RUNX cis-
regulatory module that ensures the crystal cell-specific expression of the three Drosophila melanogaster proPO. We demonstrate that activation of
this module requires the direct binding of both Srp and Lz. Interestingly, a similar GATA/RUNX signature is over-represented in crystal cell
differentiation markers, allowing us to identify new Srp/Lz target genes by genome-wide screening of Drosophila promoter regions. Finally, we
show that the expression of lz in the crystal cells also relies on Srp/Lz-mediated activation via a similar module, indicating that crystal cell fate
choice maintenance and activation of the differentiation program are coupled. Based on our observations, we propose that this GATA/RUNX cis-
regulatory module may be reiteratively used during hematopoietic development through evolution.
© 2007 Elsevier Inc. All rights reserved.Keywords: GATA; RUNX; Hematopoiesis; Drosophila; TranscriptionIntroduction
A central question in developmental biology concerns an
understanding on how multipotent progenitor cells generate a
spectrum of cell types. In this respect, the study of lineage-
specific transcription factors is of particular interest, as they
establish the gene expression programs intrinsic to cell diver-
sification. Drosophila recently appeared as a relevant model in
which to characterize the general mechanisms controlling blood
cell fate choice and differentiation. Indeed, several develop-
mental strategies and molecular pathways employed during
hematopoiesis are conserved from flies to mammals (Evans et
al., 2003). In particular, members of the GATA and RUNX
transcription factor families, which control several steps of
mammalian blood cell development, also participate in Droso-
phila hematopoiesis.⁎ Corresponding authors. Fax: +33 5 61 55 65 07.
E-mail addresses: haenlin@cict.fr (M. Haenlin), waltzer@cict.fr
(L. Waltzer).
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doi:10.1016/j.ydbio.2007.03.010Members of the GATA family contain one or two conserved
characteristic zinc fingers and bind the DNA sequence
WGATAR (Bresnick et al., 2005). In mammals, three of the
six GATA genes are reiteratively used from hematopoietic stem
cell formation to terminal differentiation into multiple blood
lineages (Bresnick et al., 2005). In Drosophila, the GATA factor
Serpent (Srp) is expressed in blood cell progenitors and its
expression is maintained in the two main classes of differ-
entiated hemocytes (Jung et al., 2005; Lebestky et al., 2000;
Rehorn et al., 1996): plasmatocytes, which function as
macrophages, and crystal cells, which are involved in melani-
zation (an insect-specific defense response). srp is required for
specification of the progenitors (Mandal et al., 2004; Rehorn et
al., 1996) and it also participates in their differentiation (Fossett
et al., 2001; Waltzer et al., 2002, 2003).
RUNX transcription factors share a highly conserved 128-
amino-acid-long DNA binding domain, the RUNT domain,
which recognizes the TGYGGTY consensus sequence (de
Bruijn and Speck, 2004). In mammals, all three RUNX factors
participate in one or more stages of hematopoiesis. In particular,
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essential for the development of definitive hematopoietic stem
cells (North et al., 1999; Okuda et al., 1996) as well as for
lymphocyte and megakaryocyte differentiation in mice (Ichi-
kawa et al., 2004). Also, RUNX1 is the most frequent target for
chromosomal translocation in human leukemia (de Bruijn and
Speck, 2004). During Drosophila hematopoiesis, the RUNX
factor Lozenge (Lz) is necessary for the formation of the
crystal cell lineage (Lebestky et al., 2000). Importantly, lz
function requires the presence of srp, and Lz physically and
functionally interacts with Srp to induce crystal cell differ-
entiation (Waltzer et al., 2003). Interestingly, the interaction
capacity between GATA and RUNX transcription factors has
been conserved through evolution (Waltzer et al., 2003) and
GATA1 and RUNX1 were shown to cooperate during mega-
karyopoiesis in vitro (Elagib et al., 2003; Xu et al., 2006).
Therefore, the cooperation between GATA and RUNX factors
plays an important role during hematopoiesis from Drosophila
to vertebrates.
InDrosophila, as in vertebrates, hematopoiesis occurs in two
waves. In the first wave, prohemocytes arise from the head
mesoderm in the early embryo, whereas in the second wave,
blood cells originate from a specialized organ, the larval lymph
gland (Holz et al., 2003). Resolution of cell fate choice is best
understood during embryogenesis (Bataillé et al., 2005). In the
embryo, the differentiation of bipotent prohemocytes into
plasmatocytes depends on the partially redundant functions of
the transcription factors Glial Cells Missing (Gcm) and Gcm2
(Alfonso and Jones, 2002; Bernardoni et al., 1997). srp appears
to play a decisive role in plasmatocyte formation because its
ectopic expression throughout the mesoderm is sufficient to
activate the expression of gcm as well as that of several other
plasmatocyte markers (Waltzer et al., 2002). On the contrary,
ectopic expression of srp alone is not sufficient to promote
crystal cell formation (Waltzer et al., 2002). Indeed, commit-
ment toward this lineage depends on the activation of lz
expression in a subset of prohemocytes and only those
maintaining lz expression differentiate into crystal cells
(Bataillé et al., 2005). Furthermore, lz expression is continu-
ously required to maintain crystal cell fate (Lebestky et al.,
2000). Therefore, it is proposed that commitment to the crystal
cell differentiation pathway relies on the maintenance of lz
expression and on the cooperation between this lineage-specific
RUNX factor and the pan-hematopoietic GATA factor Srp
(Bataillé et al., 2005). However, no direct target gene of this
GATA/RUNX complex has been identified in vivo. In addition,
how cell fate commitment and differentiation are connected is
unknown.
In order to get insights into the molecular mechanisms that
control crystal cell development, we decided to characterize
direct target genes of the Srp/Lz complex and we analyzed lz
regulatory regions to uncover how its expression is regulated.
We chose to analyze the regulatory regions of the three Dro-
sophila melanogaster prophenoloxidase (proPO) genes, which
are specific crystal cell differentiation markers (Rizki et al.,
1985). Comparison of proPO promoter sequences in Droso-
phila and other insects allowed us to identify a conservedGATA/RUNX module present in the vast majority of these
genes. Cis-elements containing this module are sufficient to
recapitulate the expression of the three D. melanogaster proPO
in embryonic and larval crystal cells. Furthermore, we show that
both Srp and Lz bind to one of these modules in vitro and that
the binding of both proteins is required for its activation in vivo.
In addition, a similar GATA/RUNX module is over-represented
in the proximal regulatory region of crystal cell markers and we
identified several new Srp/Lz target genes by using this module
as a signature for a systematic survey of all Drosophila
promoter regions. Finally, our results indicate that maintenance
of lz expression in the crystal cell lineage is also mediated by
Srp/Lz-induced transactivation of a similar cis-regulatory
module. All together, our results suggest that Srp/Lz coopera-
tion through this GATA/RUNXmodule plays a pervasive role in
crystal cell development and ensure the coupling between
lineage commitment and differentiation. As the GATA/RUNX
interaction is functionally conserved in mammals, a similar
module may be reiteratively used during hematopoietic deve-
lopment through evolution.
Materials and methods
Fly stocks
The following D. melanogaster lines were obtained from the Bloomington
Drosophila stock center: twi-gal4, lz-gal4, UAS-EGFP. Lzr1, a null allele of
lz, was kindly provided by Dr. U. Banerjee. uas-srp was previously described in
Waltzer et al. (2002). Crosses and embryo collections were performed at 25 °C.
Plasmids and transgenesis
Genomic DNA isolated from wild-type D. melanogaster was used to
amplify by PCR the putative enhancers of proPO45, proPO54, proPO59 and
lz. The PCR fragments were sequenced and cloned into pCasper-hs43-lacZ
vector. Details of the constructs are available upon request. Mutant versions of
the proPO45 and lz{144} enhancers were generated with the QuickChange
Mutagenesis kit (Stratagene) using oligonucleotides carrying mutations in each
RUNX or GATA sites.
For each construct, we established a minimum of three independent
transgenic lines by standard P-element-mediated transformation into w1118 flies.
Database search
We searched for the presence of a GATA and RUNX sites, in opposite
orientation and located within a 100-bp window, in the −500/+100 regions of
the 15,800 Drosophila promoters listed in the Genomatix database by using the
ModelInspector program of the Genomatix suite (http://www.genomatix.de). To
build our model, we used the positional weight matrix matrices representing
putative binding sites for Srp and Lz described in Senger et al. (2004) and
Wildonger et al. (2005), respectively. For each positive promoter, a sequence
spanning 50 nucleotides on both sides of the GATA/RUNX signature was used
to search for a similar signature in the Drosophila yakuba homologous genomic
region by BLAST analysis. These criteria identified conserved GATA/RUNX
signatures in 266 genes, among which we picked 50 to establish their expression
pattern by in situ hybridization.
In situ hybridizations and antibody stainings
In situ hybridizations were carried out as previously described (Waltzer et
al., 2003). Plasmids containing either the full-length cDNA or an EST were
obtained from the Drosophila Genome Resource Center and used to generate
anti-sense RNA probes.
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2000) and was used to label the crystal cells in the embryo and in the larval
lymph gland. Double fluorescent immunostaining and in situ hybridization were
carried out using DIG-UTP labeled proPO45 anti-sense probe, sheep anti-DIG
antibody (1/500) (Roche), donkey anti-sheep conjugated to Alexa Fluor 488 (1/
400) (Molecular Probe), rabbit anti-GFP antibody (1/1000) (Biolabs) and goat
anti-rabbit antibody conjugated to Alexa Fluor 555 (1/1000) (Molecular Probe).
Double fluorescent immunostaining was carried out using rabbit anti-GFP, goat
anti-rabbit antibody conjugated to Alexa Fluor 488, mouse anti-β-gal antibody
(1/500) (Promega) and goat anti-mouse antibody conjugated to Alexa Fluor 546
(1/400).
Electrophoretic mobility shift assays
Srp, Lz and control lysates were produced using the TNT-coupled
reticulocyte lysate system (Promega). Srp and Lz were transcribed from full-
length cDNA (Waltzer et al., 2003). For Srp/Lz complex identification, the two
proteins were produced in the same reaction. EMSAs were performed by
incubating 1 to 3 μl of lysate with 32P end-labeled proPO45{143} probe for 30
min at room temperature in 10 mM HEPES pH 7.9, 50 mM KCl, 1 mMMgCl2,
1 mM EDTA, 5% glycerol and 1 μg poly-dIdC in a final volume of 20 μl. For
competition experiments, double-stranded oligonucleotides containing either
wild-type or mutant GATA or RUNX sites were added to the reaction. The
reactions were loaded on a 3.6% polyacrylamide gel, 0.5× TBE and run at 4 °C
at 15 V/cm.Fig. 1. (A) Organization of the −1000/+100 regions of the three Drosophila
melanogaster proPOs. Putative binding sites for Srp (blue triangles:
WGATAR sites; filled blue triangles: HGATAABV sites corresponding to
the Srp-consensus binding sites) and Lz (red rectangles: TGYGGTY sites) are
indicated. The genomic regions used to generate the transgenic lines are
boxed. (B–I) Endogenous proPO45 expression (B and C) or lacZ expression
driven by the proPO45 (D and E), proPO54 (F and G) or proPO59 (H and I)
enhancer colocalized with lz-gal4-driven uas-GFP in the crystal cells. (B, D,
F, and H) Merged confocal dorsal view of stage 14 embryos processed to
reveal GFP protein and proPO45 (A) or lacZ (D, F and H) transcript. (C, E, G
and I) Merged confocal view of third instar larval lymph gland primary lobes
processed to reveal GFP protein and proPO45 transcript (C) or ß-gal protein
(E, G and I).Results
Identification of a conserved GATA/RUNX cis-regulatory
module in the prophenoloxidase gene family
Phenoloxidases (POs) are enzymes that catalyze the oxida-
tion of tyrosine-derived phenols to quinones (Cerenius and
Soderhall, 2004). They serve multiple tasks in insects, including
wound healing and melanotic encapsulation of pathogens. In
Drosophila, crystal cells are the main source of circulating in-
active prophenoloxidase (proPO) precursor (Rizki et al., 1985).
We previously showed that two of the three D. melanogaster
proPO (proPO54/CG5779 and proPO59/CG2952) are ex-
pressed in the crystal cells and respond to Srp/Lz-induced
activation in vivo (Waltzer et al., 2003). Similarly, the third
proPO (proPO45/CG8193) is also specifically expressed in the
crystal cell lineage in the embryo and in the larval lymph gland
(Figs. 1B and C). Furthermore, we did not detect the expression
of any of the three proPOs both in srp and in lz mutant embryos
(Supplementary information Fig. 1). Hence, the three proPOs
are coregulated in the crystal cell lineage and represent likely
direct targets for the Srp/Lz complex.
To gain insights into the regulation of the proPO family by
Srp and Lz, we searched their 5′ flanking regions for the
presence of GATA and RUNX binding sites (Fig. 1A). As the
PO-dependent melanization reaction is a conserved feature in
insects (Cerenius and Soderhall, 2004), we established the
phylogenetic relationships between most known insect POs and
we analyzed the 5′ flanking regions that we could retrieve from
54 proPOs found in 16 insect species (Supplementary
information Fig. 2). Remarkably, 47 of these proPOs display
at least one module composed of a GATA and a RUNX site
within a 100-bp window, positioned in opposite orientation, and
located less than 500 bp from the transcription start site(Supplementary information Fig. 2B). These observations
support the hypothesis that GATA and RUNX factors might
regulate proPO expression in most insects via a conserved
regulatory module.
Next, we tested whether the regions comprising this module
in the three D. melanogaster proPO were sufficient for crystal
cell-specific expression. Except for the proPO59 enhancer that
also displays some ectopic activity, lacZ expression driven by
these three cis-regulatory elements is similar to that of the
endogenous proPOs and colocalizes with lz-driven expression
of GFP (lz-gal4,uas-GFP) in the embryo (Figs. 1D, F and H)
and in the lymph gland (Figs. 1E, G and I). Hence, proximal
promoter regions containing GATA and RUNX binding sites
are sufficient to recapitulate the endogenous proPOs expres-
sion. These results suggest that the GATA/RUNX module plays
a critical role for crystal cell-specific expression of the three
proPOs in the embryo and in the larva.
Concomitant binding of Srp and Lz to their target enhancer
To further dissect the mechanisms of regulation of the pro-
POs by Srp and Lz, we concentrated on the 143-bp-long
proPO45 enhancer (Fig. 2A). Electrophoretic mobility shift
Fig. 2. Srp and Lz bind to the proPO45 enhancer. (A) Organization of the putative GATA (GS1, GS2 and GS3) and RUNX (RS1 and RS2) binding sites on the 143-bp-
long proPO45 enhancer. (B–D) EMSAs were performed with in vitro translated Srp and/or Lz. Increasing concentrations (10-, 50- and 200-folds excess) of unlabeled
wild type or mutant oligonucleotides were added to the reaction as indicated in the upper part of each panel. The likely compositions of the different retarded
complexes are indicated on the side of each panel. Mock: mock-translated reticulocyte lysate.
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(Fig. 2C) bind to this enhancer. The binding of Srp and Lz is
specific as it is efficiently competed out by an excess of cold
GATA or RUNX oligonucleotides respectively, but not by an
excess of oligonucleotides with mutated GATA or RUNX sites.
Competition experiments with oligonucleotides spanning
individual GATA (GS) or RUNX (RS) sites showed that Lz
binds to RS1 and RS2 with similar affinities while Srp displays
the highest affinity for GS2, which fits the Srp consensus
sequence (HGATAABV) previously defined by SELEX assays
(Senger et al., 2004). Srp also binds to GS3 but not to GS1.
We then asked whether Srp and Lz can simultaneously bind
this enhancer. When both Srp and Lz were incubated with the
probe, we observed two shifts that migrated higher than the
shifts observed in the presence of Lz or Srp alone (Fig. 2D).
These super-shifts represent Srp and Lz proteins bound to the
same enhancer as they are efficiently competed out both by an
excess of oligonucleotides containing either a GATA or a
RUNX site but not by an excess of oligonucleotides containing
mutated GATA or RUNX sites. Therefore, Srp and Lz can
simultaneously bind to this enhancer.
Both GATA and RUNX sites are required for Srp/Lz-induced
activation
The above experiments suggested that Srp and Lz bind
simultaneously to the proPO45 enhancer to activate its
expression in the crystal cells. Accordingly, mutations in either
the two Lz binding sites or the two Srp binding sites (GS2 and
GS3) completely abolished the proPO45 enhancer activity in
vivo (Figs. 3C and D, respectively). Of note, mutations affectinga single Lz binding site or a single Srp binding site did not alter
the activity of the enhancer (data not shown). Hence, the
number of binding sites or their relative orientation does not
appear to be critical. To confirm that binding of Srp and Lz is
required and sufficient to activate transcription from the
proPO45 enhancer, we ectopically expressed Lz and/or Srp
throughout the mesoderm using the uas-gal4 system. In line
with our previous reports on proPO54 and proPO59 (Waltzer et
al., 2003), Srp induced a very restricted activation of the
endogenous proPO45 or of the wild-type proPO45 GATA/
RUNX module (Figs. 3I and J), while Lz activated them in the
srp-expressing domains (Figs. 3E and F). Furthermore, when
Srp and Lz were coexpressed, both proPO45 and proPO45-
lacZ were strongly activated throughout the mesoderm (Figs.
3M and N). On the contrary, neither Srp or Lz nor Srp/Lz
activated the proPO45 enhancer when the two Srp binding sites
or the two Lz binding sites were mutated (Figs. 3G, H, K, L, O
and P). Thus, our results show that binding of both Srp and Lz is
required and sufficient to activate proPO45 expression.
A constrained GATA/RUNX signature is the hallmark of
Srp/Lz-responsive genes
The occurrence of a conserved GATA/RUNX module in the
Drosophila proPO genes enticed us to test whether its presence
is a more general feature of genes expressed in the crystal cell
lineage. 57 genes are reported as being expressed in the crystal
cells by the Berkeley Drosophila Genome Project (Tomancak et
al., 2002). Re-examination of their expression profile identified
34 of them as bona fide crystal cell markers (Supplementary
information Table 1). We browsed the promoter regions of these
Table 1
Classification of the 50 genes tested by in situ hybridization according to their
expression pattern and their response to Srp and/or Lz
Class I Ald, CG10602, CG11089, CG15658,
CG14269, CG6733, CG7860, mlf,
oscillin, Reg-2
Expressed in crystal cells
Class II CG10725, CG13883, CG17224,
CG18745, CG31102, CG5697,
CG6475, Dot, jon65Aiii, myo61F,
Nc73eF, Su(Tpl)
Not expressed in crystal cells,
responsive to Srp/Lz
Class III Cdk4, CG16716, CG9445,
RhoGAP88CNot expressed in crystal cells,
responsive to Srp only
Class IV CG10650, CG11874, CG11940,
CG11943, CG12493, CG13565,
CG13836, CG14183, CG14823,
CG14956, CG1826, CG2970,
CG30421, CG31086, CG32694,
CG3332, CG3744, CG4523, CG6640,
CG7328, CG8422, CG8944, dpr5,
ets96B, par-1
Not expressed in crystal cells, not
responsive to Srp, Lz or Srp/Lz
Fig. 3. The binding of both Srp and Lz is required for the activation of the proPO45 enhancer. (A–P) Side views of stage 10 to 11 embryos processed to visualize
proPO45 mRNA (A, E, I, M), or lacZ mRNA driven from the wild type proPO45 enhancer (B, F, J and N) or from the proPO45 enhancer carrying mutations in the
two Lz binding sites (C, G, K and O) or in the two Srp binding sites (D, H, L and P). Genotypes as indicated to the left of the figure.
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orientation within a 100-bp window and observed that 23.5%
(or 32.3%) of the crystal cell markers exhibit one or more
GATA/RUNX signatures in their −500/+100 (or −900/+100)
promoter region. For comparison, the occurrence of this
signature in the −500/+100 promoter region of all the Droso-
phila genes is 4.6%. Therefore, the crystal cell-specific
promoters display a significant enrichment in this GATA/
RUNX signature (P<8.4×10−6; hypergeometric variation). Of
note, when the relative orientation of the GATA and RUNX
sites is not taken into account, the proportion of positive
promoters increased by only 15% (from 23.5% to 27%) for the
crystal cell-specific genes against 71% (from 4.6% to 7.9%) for
all the Drosophila genes, leading to a decreased statistical
enrichment (P<5.3×10−5). Thus the presence of closely linked
GATA and RUNX binding sites in the proximal promoter region
seems to be a characteristic feature of crystal cell-specific genes.
Considering that this GATA/RUNX signature might be a
characteristic of Srp/Lz target genes, we searched all the D.
melanogaster genes that contained such a signature in their
proximal promoter region (see Materials and methods). We then
systematically searched whether the signature was conserved in
D. yakuba. Using these criteria, we identified 266 putative Srp/
Lz target genes (Supplementary information Table 2) of which
we randomly picked 50 for further analysis. By defining their
expression pattern in wild-type embryos as well as in embryos
ectopically expressing Srp and/or Lz throughout the mesoderm,
we categorized these genes in four classes (Table 1). Strikingly,
44% of them might represent Srp/Lz target genes. Indeed, 10
genes were expressed in the crystal cells and responded to Srp/
Lz-induced activation (Class I genes, Figs. 4A, E, I and M) and
12 genes were strongly activated upon pan-mesodermal
expression of Srp/Lz although they were not detectably
expressed in the crystal cells in wild-type embryos (Class II
genes, Figs. 4B, F, J and N). Also, we found 4 genes that were
activated by ectopic Srp expression although their activation did
not appear to be modified by Lz coexpression (Class III genes,Figs. 4C, G, K and O). On the contrary, none of the genes tested
seemed to be activated upon ectopic expression of Lz in the
absence of Srp. Finally, 24 genes were neither expressed in the
crystal cells nor activated by ectopic Srp and/or Lz (Class IV
genes, Figs. 4D, H, L and P). In conclusion, our bioinformatic
screen proved to be an efficient way to identify genes that might
be directly activated by the Srp/Lz complex.
All together, Srp/Lz-mediated gene activation via a GATA/
RUNX module may play a central role in crystal cell
differentiation by directing the coordinated expression of a
large set of genes in this lineage.
Maintenance of lz expression through a functional
GATA/RUNX module
In the course of our studies, we identified a GATA/RUNX
module in a 1.5 kb upstream element of lz that recapitulates lz
Fig. 4. Examples of expression patterns and responses to Srp and/or Lz of genes containing a GATA/RUNX signature in their promoter. (A, E, I and M) Class I genes
were expressed in the crystal cells and responded to Srp/Lz activation. (B, F, J and N) Class II genes were not detectably expressed in crystal cells but were activated in
the mesoderm upon overexpression of both Srp and Lz in this tissue. (C, G, K and O) Class III genes were activated by Srp, independently of Lz. (D, H, L and P) Class
IV genes were not regulated by Lz and/or Srp. (A–P) Lateral view of stage 11 embryos processed to reveal the expression of CG10602, CG13883, CG9445, or
CG32694 as indicated in the upper part of the figure. Genotypes as indicated to the left of the figure.
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5A). Interestingly, a similar GATA/RUNX module is also
present in the upstream region of lz in other Drosophila species
(Fig. 5A). A key aspect of crystal cell differentiation is the
maintenance of lz activity (Lebestky et al., 2000), we wondered
whether this module could mediate lz maintenance through the
activity of Srp/Lz. As shown in Fig. 5, a 144-bp element
centered on this GATA/RUNX module is sufficient to drive
lacZ expression in crystal cells in the embryo (Figs. 5B–D)
and in the lymph gland (Supplementary information Fig. 3).
Electrophoretic mobility shift assays indicated that Srp and Lz
bind specifically respectively to the GATA and RUNX sites
present in this enhancer (Supplementary information Fig. 4).
Furthermore, the recruitment of both Srp and Lz is required for
the activity of this module. Indeed, mutations of the GATA sites
or the RUNX sites completely abolished lz{144}-lacZ expres-
sion in the embryonic and larval crystal cells (Figs. 5F, G and
Supplementary information Fig. 3). Finally, the wild-type
enhancer was strongly activated by ectopic Spr/Lz expression,
whereas mutation of the GATA or the RUNX sites abolished
Srp/Lz-induced transactivation (Figs. 5H–P). All together, these
results demonstrate that this enhancer is a direct Srp/Lz target
and suggest that Srp/Lz directly maintains lz expression in the
crystal cell lineage via a conserved GATA/RUNX module.
Discussion
Ensuring the stabilization of cell fate choice and cellular
differentiation is critical for normal development. Here, we
provide evidence that these two steps are intimately coupled
during Drosophila hematopoiesis. Indeed, our results indicate
that both maintenance of the crystal cell fate choice (i.e.,
maintaining expression of the lineage-specific transcription
factor Lz) and the realization of the crystal cell differentiation
program rely on cooperation between Lz and Srp.We identified two direct target genes for Srp and Lz during
crystal cell development and showed that both proteins need to
bind simultaneously to their respective binding site for these
genes to be expressed. In humans, the glycoprotein Ibα and
αIIB promoters also contain GATA and RUNX sites and are
synergistically activated by GATA1/RUNX1 in cell culture
(Elagib et al., 2003; Xu et al., 2006). Therefore, corecruitment
of GATA and RUNX transcription factor might be a critical
aspect for GATA/RUNX synergistic transactivation. How these
factors synergize at the molecular level remains an open
question. We did not observe any cooperative DNA binding in
our in vitro assays. It is possible that simultaneous binding of
Srp and Lz allows the formation of a transactivating platform
able to recruit efficiently coactivators such as the Mediator or
chromatin modifying complexes (Levine and Tjian, 2003).
Alternatively, binding of one of the two partners may precede
gene activation and poise the enhancer for activation. For
example, during mammalian liver development, binding of the
albumin enhancer by GATA4 opens a local nucleosomal
domain and precedes gene activation, which occurs only upon
recruitment of other enhancer binding factors (Bossard and
Zaret, 1998; Cirillo et al., 2002). Hence, in the prohemocytes,
Srp may already establish the formation of crystal cell-specific
chromatin domains primed for activation.
All together, we identified the GATA/RUNX signature in 19
genes expressed in the crystal cell lineage and our results
suggest that the Srp/Lz complex directly regulates their
expression. Therefore, Srp/Lz induces crystal cell differentia-
tion by coordinating the expression of a large set of genes.
Similarly, it has been shown that Srp cooperates with members
of the Drosophila REL/NFκB family to activate several fat
body-specific immunity genes upon infection (i.e., upon nuclear
translocation of REL) (Senger et al., 2004). This cooperation
depends on closely linked REL and GATA binding sites with
the appropriate orientation. In the proPO45 enhancer, the
Fig. 5. The Srp/Lz complex directly activates lz expression. (A) Schematic representation of lz upstream regulatory regions in D. melanogaster, D. yakuba, D. pseudo-
obscura and D. virilis. Putative binding sites for Srp (blue) and Lz (red) are represented as in Fig. 1. The genomic region used to generate the lz{144}-lacZ transgenic
lines is boxed. (B–D) Dorsal views of stage 11 embryos. lacZ expression driven by the lz{144} enhancer is detected in the crystal cell cluster in stage 11 wild-type
embryos (B) but absent in a lzr1 hemizygous mutant (C), and colocalized with GFP in lz-gal4,uas-gfp embryos (D). (E–P) Lateral views of stage 11 embryos processed
to reveal lacZ expression driven from the wild-type lz{144} enhancer (E, H, K and N) or from the enhancer carrying either mutated RUNX sites (F, I, L and O) or
mutated GATA sites (G, J, M, P). Genotypes as indicated to the left side of the panels.
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does not appear to be critical in transgenic-based assays.
Nonetheless, we found that the opposite orientation of these
sites constitutes a conserved characteristic feature of crystal
cell-specific genes and thus might be important in their
endogenous genomic context. Indeed, long-range DNA
sequences play an important role in nucleosomal positioning
and the accessibility to these sites might thus be different in their
normal environment (Ioshikhes et al., 2006). In line with this
hypothesis, the GATA/RUNX signature has been conserved in
the vast majority of the proPO promoters available from distant
insect species. It is tempting to speculate that the regulation ofthe proPO expression by GATA and RUNX factors might
represent an ancestral feature. Besides being expressed in the
crystal cell lineage (our data as well as Waltzer et al., 2003 and
Crozatier et al., 2004), proPO59 was proposed to be expressed
in the lamellocytes in D. melanogaster (Irving et al., 2005).
Since the transcription factors that control lamellocyte differ-
entiation remains unknown, it could be interesting to identify
the regulatory elements required for proPO59 expression in this
lineage. While the function of the proPOs in melanization is
well established, the functions of the other genes expressed in
the crystal cells remain to be elucidated. One of them,mlf has an
homologue in mammals, which participates in erythro/myeloid
733G. Ferjoux et al. / Developmental Biology 305 (2007) 726–734differentiation (Williams et al., 1999) and is found in trans-
locations associated with acute myeloid leukemia in human
(Yoneda-Kato et al., 1996). However, the function of mlf in
Drosophila blood cell development is still unknown (Martin-
Lanneree et al., 2006).
Our bioinformatic screen, based on the presence of a
conserved GATA/RUNX signature in Drosophila, allowed us
to identify Srp/Lz-responsive genes with a high rate of success.
Similar in silico screens could help define the repertoire of
GATA/RUNX target genes in other species. Notably, the GATA/
RUNX interaction is conserved in mammals (Waltzer et al.,
2003) and it was shown that human GATA1 and RUNX1
functionally interact during hematopoiesis (Elagib et al., 2003;
Xu et al., 2006). In a preliminary analysis, we identified 383
genes that contain a GATA/RUNX signature conserved between
mouse and human (L. Waltzer, unpublished data). Strikingly,
we observed a statistical over-representation of genes asso-
ciated to normal and pathological blood cell development in
human in this list. In particular, both RUNX1 and RUNX3, but
also NFκB (p105), EVI1 (Ecotropic Virus Integration site 1)
MLL3 (Mixed Linked Leukemia 3), MKL1 (Megakaryoblastic
Leukemia 1), VWF (von Willebrand Factor) and LIF
(Leukemia Inhibitory Factor) harbor this conserved signature
in their promoter. These observations support the hypothesis
that the GATA/RUNX complex plays a critical role in hema-
topoiesis from Drosophila to mammals and suggest that the
GATA/RUNX module may be reiteratively used during
hematopoietic development through evolution.
Still, the mere presence of the GATA/RUNX signature is not
sufficient to provide responsiveness to this complex. For
instance, among the 50 genes tested in Drosophila, we
identified 4 genes that were activated by Srp alone and 16
genes that were not activated by Srp/Lz. Unfortunately, we did
not find any particular feature to discriminate between Srp/Lz
(or Srp)-responsive and non-responsive genes by simple
comparison of their cis-regulatory elements. Furthermore,
among the 22 genes activated upon ectopic expression of
Srp/Lz, 12 were not detectably expressed in the crystal cells.
This might reflect either that Srp and Lz are in limiting
concentration in the crystal cells or that these genes are
expressed in the crystal cells below our detection threshold.
Alternatively, these genes might not represent genuine Srp/Lz
targets but might be regulated by other GATA/RUNX
complexes. There are five GATA and four RUNX in Droso-
phila (Murakami et al., 2005; Rennert et al., 2003; Waltzer et
al., 2002), thus other pairs of GATA/RUNX factors might
functionally interact to regulate gene expression. Likewise,
another GATA, dGATAe cooperates with REL to mediate
antimicrobial genes activation in the larval gut (Senger et al.,
2006), whereas Srp cooperates with REL in the fat body
(Senger et al., 2004). Interestingly, Lz alone regulated none of
the genes we tested. All together, these results suggest a model
whereby the crystal cell-specific factor Lz must associate with
the pan-hematopoietic factor Srp to directly activate the
expression of the crystal cell differentiation program.
Finally, we show that the activity of the lz crystal cell-
specific enhancer also depends on GATA and RUNX bindingsites and directly requires the Srp/Lz complex. Given that lz
function is continuously required to maintain crystal cells
(Lebestky et al., 2000), our data strongly suggest that lz (and
consequently crystal cell) maintenance is achieved through an
autoregulatory loop mediated by Srp/Lz. The transition from
multipotent hematopoietic progenitors to their differentiated
progeny requires the fixation of the initial cell fate choice
(Mikkola et al., 2002). Auto-activation of a key lineage
transcription factor provides an effective mean to achieve this
fixation (Hoang, 2004). All together, our results indicate that
in the Drosophila bipotent embryonic blood cell progenitors,
Srp/Lz-mediated maintenance of lz propels both crystal cell
fate commitment and differentiation. The occurrence of a
conserved GATA/RUNX signature in the mammalian RUNX1
and RUNX3 suggests that a GATA/RUNX complex might
also regulate their expression during hematopoiesis.
In conclusion, we provide evidence that, in Drosophila,
the same complex composed of a pan-hematopoietic tran-
scription factor and of a lineage-specific transcription factor is
directly involved in maintaining the expression of the lineage-
specific partner and in coordinating the expression of a wide
array of differentiation markers. At the molecular level, this
coupling is achieved through the reiterative use of a similar
cis-regulatory element. This mechanism ensures a direct
connection between cell fate choice and differentiation and
might be observed in other developmental contexts from
Drosophila to mammals.
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